|
C15ORF44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.799900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.640250E-01 |
| Normal-vs-Stage2 |
1.764800E-01 |
| Normal-vs-Stage3 |
1.303750E-02 |
| Normal-vs-Stage4 |
2.434300E-02 |
| Stage1-vs-Stage2 |
5.402400E-01 |
| Stage1-vs-Stage3 |
9.633900E-02 |
| Stage1-vs-Stage4 |
2.122400E-01 |
| Stage2-vs-Stage3 |
6.355600E-01 |
| Stage2-vs-Stage4 |
6.640200E-01 |
| Stage3-vs-Stage4 |
9.982000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.223900E-02 |
| Normal-vs-AfricanAmerican |
8.178600E-01 |
| Normal-vs-Asian |
1.174230E-01 |
| Caucasian-vs-AfricanAmerican |
1.753150E-01 |
| Caucasian-vs-Asian |
8.800600E-01 |
| AfricanAmerican-vs-Asian |
1.642190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.040640E-01 |
| Normal-vs-Female |
3.856500E-02 |
| Male-vs-Female |
8.076800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.314200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.389900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.144400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.562420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.035200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.323900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.989600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.478800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.530600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.738200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.720400E-03 |
| Classical-VS-Follicular |
7.219700E-02 |
| Classical-VS-Other |
3.548800E-01 |
| Classical-VS-Normal |
3.825600E-01 |
| Tall-VS-Follicular |
4.004400E-01 |
| Tall-VS-Other |
8.335200E-01 |
| Tall-VS-Normal |
2.357700E-03 |
| Follicular-VS-Other |
8.989000E-01 |
| Follicular-VS-Normal |
2.919600E-02 |
| Other-VS-Normal |
1.790180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.160400E-02 |
| Normal-vs-N1 |
9.404600E-04 |
| N0-vs-N1 |
6.109600E-02 |
|
|
